- Home
- LEXX vs PVL Comparison
LEXX vs PVL Comparison
Compare LEXX & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- PVL
- Stock Information
- Founded
- LEXX 2004
- PVL 2011
- Country
- LEXX Canada
- PVL United States
- Employees
- LEXX N/A
- PVL N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- PVL Oil & Gas Production
- Sector
- LEXX Health Care
- PVL Energy
- Exchange
- LEXX Nasdaq
- PVL Nasdaq
- Market Cap
- LEXX 49.3M
- PVL 52.5M
- IPO Year
- LEXX N/A
- PVL N/A
- Fundamental
- Price
- LEXX $3.10
- PVL $1.61
- Analyst Decision
- LEXX Strong Buy
- PVL
- Analyst Count
- LEXX 2
- PVL 0
- Target Price
- LEXX $11.00
- PVL N/A
- AVG Volume (30 Days)
- LEXX 95.7K
- PVL 71.1K
- Earning Date
- LEXX 11-18-2024
- PVL 01-01-0001
- Dividend Yield
- LEXX N/A
- PVL 4.03%
- EPS Growth
- LEXX N/A
- PVL N/A
- EPS
- LEXX N/A
- PVL 0.23
- Revenue
- LEXX $411,019.00
- PVL $3,338,026.00
- Revenue This Year
- LEXX $82.02
- PVL N/A
- Revenue Next Year
- LEXX $95.09
- PVL N/A
- P/E Ratio
- LEXX N/A
- PVL $6.82
- Revenue Growth
- LEXX 34.05
- PVL N/A
- 52 Week Low
- LEXX $0.90
- PVL $1.03
- 52 Week High
- LEXX $6.85
- PVL $2.38
- Technical
- Relative Strength Index (RSI)
- LEXX 46.94
- PVL 47.51
- Support Level
- LEXX $2.92
- PVL $1.56
- Resistance Level
- LEXX $3.39
- PVL $1.76
- Average True Range (ATR)
- LEXX 0.19
- PVL 0.06
- MACD
- LEXX -0.01
- PVL -0.00
- Stochastic Oscillator
- LEXX 39.42
- PVL 53.57
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.